Also known as: Pletal (brand)
Cilostazol is a selective PDE3 inhibitor that inhibits platelet aggregation and causes vasodilation. It is used for the treatment of intermittent claudication in peripheral arterial disease and for prevention of secondary stroke. Mediocon Inc supplies pharmaceutical-grade Cilostazol meeting IP/BP/EP/USP standards.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | 99.0% Min. |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Cilostazol (CAS 73963-72-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Cilostazol is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance